This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sakuma, T. Articles by Yasuda, J. Search for Related Content PubMed PubMed Citation Articles by Sakuma, T. Articles by Yasuda, J. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene

 Previous Article  |  Next Article 

Journal of Virology, March 2009, p. 2382-2385, Vol. 83, No. 5
0022-538X/09/$08.00+0     doi:10.1128/JVI.01607-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Inhibition of Lassa and Marburg Virus Production by Tetherin

Toshie Sakuma,¹ Takeshi Noda,² Shuzo Urata,¹ Yoshihiro Kawaoka,^2,3 and Jiro Yasuda^1*

First Department of Forensic Science, National Research Institute of Police Science, Kashiwa 277-0882, Japan,¹ Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan,² Department of Pathological Sciences, School of Veterinary Medicine, University of Wisconsin—Madison, Madison, Wisconsin 53706³

Received 29 July 2008/ Accepted 2 December 2008

Recently, tetherin has been identified as an effective cellular factor that prevents the release of human immunodeficiency virus type 1. Here, we show that the production of virus-like particles induced by viral matrix proteins of Lassa virus or Marburg virus was markedly inhibited by tetherin and that N-linked glycosylation of tetherin was dispensable for this antiviral activity. Our data also suggest that viral matrix proteins or one or more components that originate from host cells are targets of tetherin but that viral surface glycoproteins are not. These results suggest that tetherin inhibits the release of a wide variety of enveloped viruses from host cells by a common mechanism.

---

* Corresponding author. Mailing address: First Department of Forensic Science, National Research Institute of Police Science, 6-3-1 Kashiwanoha, Kashiwa 277-0882, Japan. Phone: 81-4-7135-8001. Fax: 81-4-7133-9159. E-mail: yasuda{at}nrips.go.jp

Published ahead of print on 17 December 2008.

---

Journal of Virology, March 2009, p. 2382-2385, Vol. 83, No. 5
0022-538X/09/$08.00+0     doi:10.1128/JVI.01607-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Lim, E. S., Emerman, M. (2009). Simian Immunodeficiency Virus SIVagm from African Green Monkeys Does Not Antagonize Endogenous Levels of African Green Monkey Tetherin/BST-2. J. Virol. 83: 11673-11681 [Abstract] [Full Text]  
• Brohm, C., Steinmann, E., Friesland, M., Lorenz, I. C., Patel, A., Penin, F., Bartenschlager, R., Pietschmann, T. (2009). Characterization of Determinants Important for Hepatitis C Virus p7 Function in Morphogenesis by Using trans-Complementation. J. Virol. 83: 11682-11693 [Abstract] [Full Text]  
• Le Tortorec, A., Neil, S. J. D. (2009). Antagonism to and Intracellular Sequestration of Human Tetherin by the Human Immunodeficiency Virus Type 2 Envelope Glycoprotein. J. Virol. 83: 11966-11978 [Abstract] [Full Text]  
• Rong, L., Zhang, J., Lu, J., Pan, Q., Lorgeoux, R.-P., Aloysius, C., Guo, F., Liu, S.-L., Wainberg, M. A., Liang, C. (2009). The Transmembrane Domain of BST-2 Determines Its Sensitivity to Down-Modulation by Human Immunodeficiency Virus Type 1 Vpu. J. Virol. 83: 7536-7546 [Abstract] [Full Text]